William Joseph Brunken

Title: The Innovations of William Joseph Brunken

Introduction

William Joseph Brunken is a notable inventor based in Canton, MA (US). He has made significant contributions to the field of biomedical research, particularly in the area of collagen and nucleic acid molecules. With a total of 7 patents to his name, Brunken's work has had a profound impact on medical science.

Latest Patents

Brunken's latest patents include groundbreaking inventions such as β netrin and its uses. This patent provides β-netrin nucleic acid molecules and polypeptides, along with methods for utilizing these components. Another significant patent is for Collagen XXII, a novel human collagen and its applications. This invention encompasses isolated nucleic acid molecules that encode a new type of collagen, as well as antisense nucleic acid molecules, recombinant expression vectors, and host cells that incorporate these vectors. Additionally, it includes nonhuman transgenic animals with introduced or disrupted collagen XXII genes, isolated collagen XXII proteins, fusion proteins, antigenic peptides, and anti-collagen XXII antibodies. Diagnostic methods utilizing these compositions are also part of this innovative work.

Career Highlights

Throughout his career, Brunken has worked with esteemed organizations such as The General Hospital Corporation and Tufts University. His research has been pivotal in advancing our understanding of collagen and its implications in human health.

Collaborations

Brunken has collaborated with notable colleagues, including Robert E. Burgeson and Manuel Koch. Their combined expertise has contributed to the success of various research projects and innovations.

Conclusion

William Joseph Brunken's contributions to the field of biomedical research through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in medical science and technology.